The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells
Endocrinology · 01.07.2022 · 163 (7)
DOI: 10.1210/endocr/bqac072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 15.05.2022. Verfasst von Liqian Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Integrative Physiology, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA. Hauptthemen laut MEDLINE: Liver X Receptors, Mammary Neoplasms, Experimental, Myeloid Cells, Receptors, Steroid. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Dysregulation of cholesterol homeostasis is associated with many diseases such as cardiovascular disease and cancer. Liver X receptors (LXRs) are major upstream regulators of cholesterol homeostasis and are activated by endogenous cholesterol metabolites such as 27-hydroxycholesterol (27HC). LXRs and various LXR ligands such as 27HC have been described to influence several extra-hepatic biological systems. However, disparate reports of LXR function have emerged, especially with respect to immunology and cancer biology. This would suggest that, similar to steroid nuclear receptors, the LXRs can be selectively modulated by different ligands. Here, we use RNA-sequencing of macrophages and single-cell RNA-sequencing of immune cells from metastasis-bearing murine lungs to provide evidence that LXR satisfies the 2 principles of selective nuclear receptor modulation: (1) different LXR ligands result in overlapping but distinct gene expression profiles within the same cell type, and (2) the same LXR ligands differentially regulate gene expression in a highly context-specific manner, depending on the cell or tissue type. The concept that the LXRs can be selectively modulated provides the foundation for developing precision pharmacology LXR ligands that are tailored to promote those activities that are desirable (proimmune), but at the same time minimizing harmful side effects (such as elevated triglyceride levels).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Integrative Physiology, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
- Department of Computer Science, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
- NYU Cardiovascular Research Center, Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY 10016, USA.
- Roy J. Carver Biotechnology Center DNA Services, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
- Department of Cell Biology, New York University School of Medicine, New York, NY 10032, USA.
- Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
ORCID-Profile: Payam Dibaeinia, Erik R Nelson
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- National Cancer Institute
- National Institutes of Health
- Department of Defense Breast Cancer Research Program Era of Hope Scholar Award
- American Institute for Cancer Research
- National Heart, Lung, and Blood Institute
Zitieren
APA
Ma, L., Vidana Gamage, H. E., Tiwari, S., Han, C., Henn, M. A., Krawczynska, N., Dibaeinia, P., Koelwyn, G. J., Das Gupta, A., Bautista Rivas, R. O., Wright, C. L., Xu, F., Moore, K. J., Sinha, S., & Nelson, E. R. (2022). The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells. Endocrinology, 163(7). https://doi.org/10.1210/endocr/bqac072
Vancouver
Ma L, Vidana Gamage HE, Tiwari S, Han C, Henn MA, Krawczynska N, et al. The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells. Endocrinology. 2022;163(7). doi:10.1210/endocr/bqac072
BibTeX
@article{Ma2022,
author = {Ma, Liqian and Vidana Gamage, Hashni Epa and Tiwari, Srishti and Han, Chaeyeon and Henn, Madeline A and Krawczynska, Natalia and Dibaeinia, Payam and Koelwyn, Graeme J and Das Gupta, Anasuya and Bautista Rivas, Rafael Ovidio and Wright, Chris L and Xu, Fangxiu and Moore, Kathryn J and Sinha, Saurabh and Nelson, Erik R},
title = {The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells},
journal = {Endocrinology},
year = {2022},
volume = {163},
number = {7},
doi = {10.1210/endocr/bqac072}
}
EUVIMED